Used primarily in scientific research to study the serotonin 5-HT2B receptor, RS 127445 serves as a selective antagonist. It helps investigate the role of 5-HT2B receptors in cardiovascular function, neurology, and psychiatric disorders. Due to its high selectivity, it is valuable in experiments aiming to block 5-HT2B receptor activity without affecting related serotonin receptors. This compound is not used clinically but supports the development of therapeutics targeting serotonin-related pathways, particularly in conditions involving cardiac fibrosis and certain cancers where 5-HT2B signaling may play a role.